High ETS2 expression predicts poor prognosis in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation

Ann Hematol. 2019 Feb;98(2):519-525. doi: 10.1007/s00277-018-3440-4. Epub 2018 Jul 18.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Allografts
  • Disease-Free Survival
  • Female
  • Gene Expression Regulation, Leukemic*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myeloid, Acute / metabolism*
  • Leukemia, Myeloid, Acute / mortality*
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Middle Aged
  • Proto-Oncogene Protein c-ets-2 / biosynthesis*
  • Survival Rate

Substances

  • ETS2 protein, human
  • Proto-Oncogene Protein c-ets-2